[The effect of Calciparin on diethylnitrosamine induced liver neoplasms in the rat].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D005966:Glucuronidase / Q000378:metabolism; D006493:Heparin / Q000627:therapeutic use*; D006596:Hexosaminidases / Q000378:metabolism; D006821:Hyaluronoglucosaminidase / Q000378:metabolism; D008113:Liver Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000201:enzymology; D009602:Nitrosamines; D051381:Rats
D000970:Antineoplastic Agents; D009602:Nitrosamines; D006493:Heparin; D006596:Hexosaminidases; D005966:Glucuronidase; D006821:Hyaluronoglucosaminidase; D002118:Calcium
Einflubb von Calciparin auf durch Diaethylnitrosamin erzeugte Lebertumoren der Ratte.